首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING MARINE FUNGUS PENICILLIUM SP. SF-5859-DERIVED CURVULARIN-TYPE METABOLITES

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING MARINE FUNGUS PENICILLIUM SP. SF-5859-DERIVED CURVULARIN-TYPE METABOLITES

机译：用于预防或治疗炎症性疾病的组合物，含有海洋真菌青霉素SP。 SF-5859-衍生的Curvularin型代谢物

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases and a food for preventing or alleviating inflammatory diseases, both of which contain curvularin-type metabolites as an active ingredient and, more specifically to a pharmaceutical composition for preventing or treating inflammatory diseases and a food for preventing or alleviating inflammatory diseases, both of which contain, as an active ingredient, marine fungus Penicillium sp. SF-5859-derived curvularin-type metabolites. A pharmaceutical composition, according to the present invention, for preventing or treating inflammatory diseases, containing curvularin-type metabolites derived from marine fungus Penicillium sp. SF-5859 (KCTC 13354 BP) inhibits the production of proinflammatory cytokines and mediators, thereby being effectively usable for the prevention or treatment of inflammatory diseases.

机译：本发明涉及用于预防或治疗炎性疾病的药物组合物和用于预防或缓解炎性疾病的食物，其中两者含有曲波霉素型代谢物作为活性成分，更具体地含有用于预防或治疗炎性疾病的药物组合物和用于预防或缓解炎性疾病的食物，两者都含有活性成分，作为活性成分，海洋真菌 Penicillium Sp。 SF-5859衍生的Curvularin型代谢物。根据本发明的药物组合物用于预防或治疗炎性疾病，含有衍生自船舶真菌的曲波蛋白型代谢物 Penicillium Sp。 SF-5859（KCTC 13354 BP）抑制促炎细胞因子和介质的产生，从而有效地用于预防或治疗炎性疾病。

著录项

公开/公告号US2021177796A1

专利类型
公开/公告日2021-06-17

原文格式PDF
申请/专利权人 KOREA INSITITUTE OF OCEAN SCIENCE AND TECHNOLOGY;
展开▼

申请/专利号US201816759281
发明设计人 JOUNG HAN YIM;IL-CHAN KIM;SE JONG HAN;UI JOUNG YOUN;HYUN CHEOL OH;YOUN-CHUL KIM;JAE HAK SOHN;MINH HA TRAN;WONMIN KO;SEUNG JUN LEE;JAE-YOUNG SON;
展开▼

申请日2018-02-28
分类号A61K31/335;A61K36/06;A23L31;
国家 US
入库时间 2022-08-24 19:24:45

相似文献

专利
外文文献
中文文献

1. Eremophilane sesquiterenes from the marine fungus Penicillium sp. BL27-2 [J] . Yong Fu Huang, Li Qiao, A.Li Lv, 中国化学快报（英文版） . 2008,第005期

2. Cytotoxic and antibacterial substances against multi-drug resistant pathogens from marine sponge symbiont:Citrinin,a secondary metabolite of Penicillium sp. [J] . Ramesh, Subramani, Rohitesh, 亚太热带生物医学杂志：英文版 . 2013,第004期

3. Metabolites of Marine Fungus Aspergillus sp. Collected from Soft Coral Sarcophyton tortuosum [J] . LI Hou-jin, CAI Yong-tong, CHEN Yun-yun, 高等学校化学研究：英文版 . 2010,第003期

4. Citrinal A, a novel tricyclic derivative of citrinin,from an algicolous fungus Penicillium sp. i-1-1 [J] . Tian Jiao Zhu, Lin Du, Peng Fei Hao, 中国化学快报（英文版） . 2009,第008期

5. Fermentation Conditions Optimization of Anti-tumor Active Metabolites from Marine Penicillium sp. HGQ6 [C] . Lei Guo, Wencheng Zhu, Chao Liu International Conference on Mechanical Properties of Materials and Information Technology . 2011

6. Studies on nitrogen-containing secondary metabolites from terrestrial and marine origin: Part I. Enzymatic epoxidation of 2,5-dihydroxyacetanilide in Streptomyces sp. Part II. Synthesis of marine sponge alkaloids: Slagenins, axinohydantoins, and studies towards the pyrrolopiperazine system in the agelastatin core. [D] . Barrios Sosa, Ana Carolina. 2002

7. Anti-Inflammatory Effects of Curvularin-Type Metabolites from a Marine-Derived Fungal Strain Penicillium sp. SF-5859 in Lipopolysaccharide-Induced RAW264.7 Macrophages [O] . Tran Minh Ha, Wonmin Ko, Seung Jun Lee, 2017

8. Anti-Inflammatory Effects of Curvularin-Type Metabolites from a Marine-Derived Fungal Strain Penicillium sp. SF-5859 in Lipopolysaccharide-Induced RAW264.7 Macrophages [O] . Tran Ha, Wonmin Ko, Seung Lee, 2017

1. Optimal Parameters for in Vitro Development of the Fungus Hydrocarbonoclastic Penicillium sp. [J] . Marcia Eugenia Ojeda-Morales ,Miguelángel Hernández-Rivera ,JoséGabriel Martínez-Vázquez . 化学工程与科学期刊（英文） . 2013,第4期

2. 海洋真菌Hypoxylon sp．低沸点代谢物的研究 [C] . . 中国第五届海洋湖沼药物学术开发研讨会 . 1998

3. 海洋真菌代谢物及其衍生物和载金属离子纳米材料制备与生物活性的研究 [A] . 张奕 . 2008